UB Paderborn / Katalog / Suche / in CDI

Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production

International immunology, 1999-07, Vol.11 (7), p.1169-1179

1999

Link zum Volltext

Verfügbarkeit prüfen

The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease

The Journal of immunology (1950), 2002-12, Vol.169 (12), p.6720-6732

2002

Link zum Volltext

Verfügbarkeit prüfen

Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate

The Journal of immunology (1950), 2002-09, Vol.169 (5), p.2231-2235

2002

Link zum Volltext

Verfügbarkeit prüfen

Astrocytes Express Elements of the Class II Endocytic Pathway and Process Central Nervous System Autoantigen for Presentation to Encephalitogenic T Cells

The Journal of immunology (1950), 1998-12, Vol.161 (11), p.5959-5966

1998

Link zum Volltext

Verfügbarkeit prüfen

Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-γ-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T-cell activation

Glia, 2001-12, Vol.36 (3), p.391-405

2001

Link zum Volltext

Verfügbarkeit prüfen

Staphylococcal Enterotoxins can Reactivate Experimental Allergic Encephalomyelitis

Proceedings of the National Academy of Sciences - PNAS, 1993-09, Vol.90 (18), p.8543-8546

1993

Link zum Volltext

Verfügbarkeit prüfen

Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species

Clinical immunology (Orlando, Fla.), 2003-11, Vol.109 (2), p.188-196

2003

Link zum Volltext

Verfügbarkeit prüfen

Intramolecular epitope spreading induced by staphylococcal enterotoxin superantigen reactivation of experimental allergic encephalomyelitis

Journal of neuroimmunology, 2002-02, Vol.123 (1), p.30-34

2002

Link zum Volltext

Verfügbarkeit prüfen

Oral feeding of interferon τ can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis

Journal of neuroimmunology, 1997-05, Vol.75 (1), p.43-50

1997

Link zum Volltext

Verfügbarkeit prüfen

CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitis

Journal of neuroimmunology, 1997-05, Vol.75 (1), p.35-42

1997

Link zum Volltext

Verfügbarkeit prüfen

IMMUNOPHARMACOLOGY OF RECOMBINANT HUMAN INTERLEUKIN-18 IN NON-HUMAN PRIMATES

Cytokine (Philadelphia, Pa.), 2002-10, Vol.20 (1), p.38-48

2002

Link zum Volltext

Verfügbarkeit prüfen

Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity

The Journal of clinical investigation, 2001-10, Vol.108 (8), p.1133-1139

2001

Link zum Volltext

Verfügbarkeit prüfen

The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity

The Journal of immunology (1950), 1995-09, Vol.155 (5), p.2747

1995

Link zum Volltext

Verfügbarkeit prüfen

Superantigens: Structure and Relevance to Human Disease

Proceedings of the Society for Experimental Biology and Medicine, 1996-06, Vol.212 (2), p.99-109

1996

Link zum Volltext

Verfügbarkeit prüfen

Perspectives on FIV vaccine development

Vaccine, 1997-08, Vol.15 (12), p.1437-1444

1997

Link zum Volltext

Verfügbarkeit prüfen

Accelerated Induction of Experimental Allergic Encephalomyelitis in PL/J Mice by a Non-Vβ8-Specific Superantigen

Proceedings of the National Academy of Sciences - PNAS, 1995-06, Vol.92 (13), p.6082-6086

1995

Link zum Volltext

Verfügbarkeit prüfen

Interferon-??: Prospects for Clinical Use in Autoimmune Disorders

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 1999, Vol.11 (2), p.125-135

1999

Link zum Volltext

Verfügbarkeit prüfen

Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis

Journal of neuroimmunology, 1993-03, Vol.43 (1), p.39-43

1993

Link zum Volltext

Verfügbarkeit prüfen

Interferon-tau: prospects for clinical use in autoimmune disorders

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 1999-02, Vol.11 (2), p.125-135

1999

Link zum Volltext

Verfügbarkeit prüfen

Multiple Binding-Sites on the Superantigen, Staphylococcal Enterotoxin B, Imparts Versatility in Binding to MHC Class II Molecules

Biochemical and biophysical research communications, 1994-06, Vol.201 (2), p.596-602

1994

Link zum Volltext

Verfügbarkeit prüfen

Type I interferon inhibition of superantigen stimulation: implications for treatment of superantigen-associated disease

Journal of interferon & cytokine research, 1995-01, Vol.15 (1), p.39-45

1995

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulation of experimental allergic encephalomyelitis (EAE) by superantigen and type I interferon

Journal of neuroimmunology, 1994-10, Vol.54 (1), p.199-199

1994

Link zum Volltext

Verfügbarkeit prüfen

Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-Vbeta8-specific superantigen

Proceedings of the National Academy of Sciences - PNAS, 1995-06, Vol.92 (13), p.6082

1995

Link zum Volltext

Verfügbarkeit prüfen

Identification of Binding Domains on the Superantigen, Toxic Shock Syndrome-1, for Class II MHC Molecules

Biochemical and biophysical research communications, 1993-03, Vol.191 (3), p.1211-1217

1993

Link zum Volltext

Verfügbarkeit prüfen

Rheumatoid Arthritis and Related Autoimmune Diseases, Animal Models

Encyclopedia of Immunotoxicology, p.781-783

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production

The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease

Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate

Astrocytes Express Elements of the Class II Endocytic Pathway and Process Central Nervous System Autoantigen for Presentation to Encephalitogenic T Cells

Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-γ-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T-cell activation

Staphylococcal Enterotoxins can Reactivate Experimental Allergic Encephalomyelitis

Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species

Intramolecular epitope spreading induced by staphylococcal enterotoxin superantigen reactivation of experimental allergic encephalomyelitis

Oral feeding of interferon τ can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis

CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitis

IMMUNOPHARMACOLOGY OF RECOMBINANT HUMAN INTERLEUKIN-18 IN NON-HUMAN PRIMATES

Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity

The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity

Superantigens: Structure and Relevance to Human Disease

Perspectives on FIV vaccine development

Accelerated Induction of Experimental Allergic Encephalomyelitis in PL/J Mice by a Non-Vβ8-Specific Superantigen

Interferon-??: Prospects for Clinical Use in Autoimmune Disorders

Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis

Interferon-tau: prospects for clinical use in autoimmune disorders

Multiple Binding-Sites on the Superantigen, Staphylococcal Enterotoxin B, Imparts Versatility in Binding to MHC Class II Molecules

Type I interferon inhibition of superantigen stimulation: implications for treatment of superantigen-associated disease

Immunomodulation of experimental allergic encephalomyelitis (EAE) by superantigen and type I interferon

Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-Vbeta8-specific superantigen

Identification of Binding Domains on the Superantigen, Toxic Shock Syndrome-1, for Class II MHC Molecules

Rheumatoid Arthritis and Related Autoimmune Diseases, Animal Models

Suchergebnisse filtern